Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center